Skip to main content
Clinical Trials/NCT06245720
NCT06245720Active, not recruitingNot Applicable

Serum and Urine Metabolome Studies in Patients With Acute Kidney Injury After Cardiac Surgery

Nanjing First Hospital, Nanjing Medical University1 site in 1 country200 target enrollmentStarted: January 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
200
Locations
1
Primary Endpoint
serum and urine metabolome studies

Study Overview

Brief Summary

The goal of this observational study is to learn about serum and urine metabolome in patients after cardiac surgery.

Detailed Description

The main objective of this study is to collect blood and urine samples from patients after cardiac surgery, and to perform metabolomic analysis to find the differential metabolites and their enrichment pathways in AKI patients and non-AKI patients.The secondary objective is to intervene in its enrichment pathway to find ways to improve CSA-AKI.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age> 18 years old;
  • after cardiopulmonary bypass;

Exclusion Criteria

  • Under the age of 18;
  • Previous chronic kidney disease or receiving renal replacement therapy;
  • Have a history of kidney transplantation or nephrectomy.

Outcomes

Primary Outcomes

serum and urine metabolome studies

Time Frame: January 2025 - December 2025

The preoperative and postoperative metabolomic differences in blood and urine between AKI group and non-AKI group were compared.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials